Developing a national system for dealing with adverse events following immunization.
Although vaccines are among the safest of pharmaceuticals, the occasional severe adverse event or cluster of adverse events associated with their use may rapidly become a serious threat to public health. It is essential that national monitoring and reporting systems for vaccine safety are efficient and adequately coordinated with those that conventionally deal with non-vaccine pharmaceuticals. Equally important is the need for an enlightened and informed national system to be in place to deal with public concerns and rapid evaluation of the risk to public safety when adverse events occur. Described in this article is the outcome of efforts by the WHO Global Training Network to describe a simple national system for dealing with vaccine safety and with emergencies as they arise. The goals of a training programme designed to help develop such a system are also outlined.
Mehta
U
U
National Adverse Drug Event Monitoring Centre, University of Cape Town, Observatory, South Africa. umehta@uctgsh1.uct.ac.za
Milstien
J B
JB
Duclos
P
P
Folb
P I
PI
D016907:Adverse Drug Reaction Reporting Systems; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D007318:Inservice Training; D011159:Population Surveillance; D014612:Vaccines / Q000009:adverse effects*
D014612:Vaccines